Concentration of cadmium, nickel and aluminium in female breast cancer

Polish Journal of Pathology

Volumn 62, Issue 4, 2011, Pages 257-261

  Romanowicz Makowska, Hanna ^a   Forma, Ewa ^b   Bryś, Magdalena ^b   Małgorzata Krajewska, Wanda ^b   Smolarz, Beata ^a  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Aluminium; Cadmium; Female breast cancer.; Nickel

Indexed keywords

ALUMINUM DERIVATIVE; CADMIUM DERIVATIVE; NICKEL;

ADULT; AGED; ARTICLE; BREAST; BREAST TUMOR; CANCER STAGING; CHEMISTRY; FEMALE; HUMAN; MENOPAUSE; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY;

ADULT; AGED; ALUMINUM COMPOUNDS; BREAST; BREAST NEOPLASMS; CADMIUM COMPOUNDS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; NEOPLASM STAGING; NICKEL;

EID: 84855788943     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. IARC (International Agency for Research on Cancer). Beryllium, cadmium,mercury, and exposures in the glassmanufacturing industry. In:Monographs on the evaluation of carcinogenic risks of humans, 1993, 58, Lyon, France.
2. IARC (International Agency for Research on Cancer). (1990) Chromium, nickel and welding. In: Monographs on the evaluation of carcinogenic risks of humans, 1990, 49, Lyon, France.
3. Waisberg M, Joseph P, Hale B, et al. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 2003; 192: 95-117.
4. Waalkes MP. Cadmium carcinogenesis in review. J Inorg Biochem 2000; 70: 241-244.
5. Kasprzak KS, Sunderman FW Jr, Salnikow K. Nickel carcinogenesis. Mutat Res 2003; 533: 67-97.
6. Filipic M, Fatur T, Vudrag M. Molecular mechanisms of cadmium induced mutagenicity. Hum Exp Toxicol 2006; 25: 67-77.
7. Martelli A, Rousselet E, Dycke C, et al. Cadmium toxicity in animal cells by interference with essential metals. Biochemie 2006; 88: 1807-1814.
8. ATSDR (Agency for Toxic Substances and Disease Registry) US Public Health Service. Toxicological profile of nickel. Atlanta, GA: US Department of Health and Human Services, Public Health Services, 2005.
9. Denkhaus E, Salnikow K. Nickel essentiality, toxicity, and carcinogenicity. Crit Rev Oncol Hematol 2002; 42: 35-56.
10. Barceloux DG. Nickel. Clin Toxicol 1999; 37: 239-258.
11. Godt J, Scheidig F, Grosse-Siestrup C, et al. The toxicity of cadmiumand resulting hazards for human health. JOccupMed Toxicol 2006; 1: 22-27.
12. Satarug S, Baker JR, Reilly PE, et al. Changes in zinc and copper homeostasis in human livers and kidneys associated with exposure to environmental cadmium. Hum Exp Toxicol 2001; 20: 205-213.
13. Antila E, Mussalo-Rauhamaa H, Kantola M, et al. Association of cadmium with human breast cancer. Sci Total Environ 1996; 186: 251-256.
14. Vahter M, Berglund M, Akesson A, et al. Metals and women's health. Environ Res A 2002; 88: 145-155.
15. Sivulka DJ. Assessment of respiratory carcinogenicity associated with exposure tometallic nickel: A review. Regul Toxicol Pharmacol 2005; 43: 117-133.
16. ATSDR (Agency for Toxic Substances and Disease Registry). US Public Health Service. Toxicological profile of aluminum. Atlanta, GA: US Department ofHealth andHuman Services, Public Health Services, 2006.
17. Becaria A, Campbell A, Bondy SC. Aluminumas a toxicant. Toxicol Ind Health 2002; 18: 309-320.
18. Soni MG, White SM, Flamm WG, et al. Safety evaluation of dietary aluminum. Regul Toxicol Pharmacol 2001; 33: 66-79.
19. Yokel RA, McNamara G. Aluminium toxicokinetics: an update minireview. Pharmacol Toxicol 2001; 88: 159-167.
20. Darbre PD. Environmental oestrogens, cosmetics and breast cancer. Best Pract Res Clin Endocrinol Metab 2006; 20: 121-143.
21. Darbre PD. Aluminium, antiperspirants and breast cancer. J Inorg Biochem 2005; 99: 1912-1919.
22. Bloom H, Richardson W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359-377.
23. Sobczuk A, Smolarz B, Romanowicz-MakowskaH, Pertynski T. Rola polimorfizmów pojedynczych nukleotydów (SNP) w obrebie genów mechanizmów naprawy DNA przez rekombinacje RAD51, XRCC2, XRCC3 i XRCC4 w patogenezie raka piersi u kobiet w wieku pomenopauzalnym. Prz Menopauz 2009; 4: 228-232
24. Romanowicz H, Smolarz B, Baszczynski J, et al. Genetics polymorphism in DNA repair genes by base excision repair pathway (XRCC1) and homologous recombination (XRCC2 and RAD51) and the risk of breast carcinoma in the Polish population. Pol J Pathol 2010; 61: 206-212.
25. Pearson CA, Prozialeck WC. E-cadherin, ß-catenin and cadmium carcinogenesis. Med Hypotheses 2001; 56: 573-581.
26. Beavon IRG. The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer 2000; 36: 1607-1620.
27. Martin MB, Reiter R, Pham T, et al. Estrogen-like activity of metals in Mcf-7 breast cancer cells. Endocrinology 2003; 144: 2425-2436.
28. Brama M, Gnessi L, Basciani S, et al. Cadmium induces mitogenic signaling in breast cancer cell by an ERa-dependentmechanism. Mol Cell Endocrinol 2007; 264: 102-108.
29. Stoica A, Katzenellenbogen, Martin MB. Activation of estrogen receptor-? by the heavy metal cadmium. Mol Endocrinol 2000; 14: 545-553.